BiotechTube
Home/OrsoBio/Rob Myers, MD
RM

Rob Myers, MD

Chief Medical Officer and Head of Development

OrsoBio

Therapeutic Areas

Metabolic DiseasesLiver DiseasesObesityDiabetesDyslipidemias

OrsoBio Pipeline

DrugIndicationPhase
TLC-2716Severe Hypertriglyceridemia and Metabolic Liver DiseasePhase 2a
TLC-1180Obesity (potential combination therapy)Preclinical

Leadership Team at OrsoBio

MS
Mani Subramanian, MD, PhD
CEO and Founder
GG
Gans Ganapati
Co-Founder and Chief Business and Financial Officer
View full OrsoBio profile